Thu Aug 26 2021

suPAR: An exciting biomarker of systemic chronic inflammation.

suPAR provides a more stable biomarker of systemic chronic inflammation than CRP or IL-6 and is less subject to the influence of acute infection and environmental exposures.

New Article exciting biomarker suPAR

Exposure to adverse life experiences associates with increased morbidity and mortality from a range of diseases in later life. Growing evidence suggests that systemic inflammation may contribute to these relationships, with early childhood adversity and stressful life experiences in adulthood.

Higher suPAR levels predict poorer prognosis across conditions, accelerated biological aging, and mortality both in clinical and healthy populations. In sum, suPAR is recognized as a nonspecific marker of systemic chronic inflammation that is common to many inflammatory diseases and may serve as a marker of health risk in the general population.

Conclusion: suPAR is an exciting biomarker that may provide a more stable measure of systemic chronic inflammation and supplement more traditional markers of inflammation in the prediction of health risk.

+800

published suPAR studies in leading medical journals

Nature Medicine Logo
Science Journal Logo
JAMA Pediatrics Logo

The suPARnostic® brand consists of 3 products:

Photo of The suPARnostic® Quick Triage kit

Quick Triage

A Point of Care Solution

Photo of suPARnostic® TurbiLatex

TurbiLatex

For Automated Systems

Photo of suPARnostic® ELISA

ELISA Assay

Clinical and Research

suPAR is used in clinical routine in 38 hospitals

38 hospitals use suPAR in clinical routine for triage of patients in the Emergency Departments and COVID-19 units. Clinical routine is defined by the placement of two Purchasing Orders within the last 12 months rolling. This period covers October 1, 2021, until September 30, 2022.
Some hospital locations cannot be disclosed due to confidentiality.

New Webinar

Webinar

Catch COVID-19

-Improve your triage

Sign up to view webinar recording

View recording

suPARnostic® by ViroGates